...
首页> 外文期刊>Pediatric Nephrology >Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial prophylaxis really needed?
【24h】

Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial prophylaxis really needed?

机译:患有输尿管盆腔连接阻塞的婴儿尿路感染的可能性:真的需要进行抗菌预防吗?

获取原文
获取原文并翻译 | 示例
           

摘要

In infants with ureteropelvic junction obstruction (UPJO), the risk of urinary tract infection (UTI) is unknown, and there is a lack of prospective studies showing definitive evidence regarding the benefits and necessity of antibiotic prophylaxis. The aim of this study was to assess the risk of UTI in infants with UPJO and to determine whether the risk varies according to the degree of hydronephrosis. Infants with hydronephrosis detected prenatally or within the postnatal 28th day and who had no previous history of UTI were followed prospectively without antibacterial prophylaxis. Imaging studies were performed according to our Pediatric Uro-Nephrology Study Group protocol. Dimercaptosuccinate (DMSA) scintigraphy was performed in all infants at the end of 1 year of follow-up. Eighty-four infants (56 boys, 28 girls) were included in the study. The distribution of patients in each hydronephrosis grading group was incidentally similar. Within a median follow-up period of 18 (12–24) months, none of the patients had UTI. Furthermore, no pyelonephritic scar was found on DMSA scans in any patient. We conclude that prophylactic antibiotic usage is not indicated in infants with UPJO, regardless of the severity of hydronephrosis, as the risk of UTI is minimal in this population.
机译:在患有输尿管盆腔连接梗阻(UPJO)的婴儿中,尿路感染(UTI)的风险尚不清楚,并且缺乏前瞻性研究来显示有关预防抗生素的益处和必要性的确切证据。这项研究的目的是评估UPJO婴儿患UTI的风险,并确定该风险是否因肾积水程度而异。出生前或出生后第28天发现有肾积水的婴儿,以前没有UTI病史,因此对他们进行了前瞻性随访,未进行抗菌预防。影像学检查是根据我们的儿科泌尿肾病研究小组的方案进行的。在随访的1年末对所有婴儿进行了二巯基琥珀酸酯(DMSA)闪烁显像。这项研究包括了84名婴儿(56名男孩,28名女孩)。每个肾积水分级组的患者分布偶然相似。在中位随访期18(12-24)个月内,所有患者均未发生UTI。此外,在任何患者中,DMSA扫描均未发现肾盂肾炎疤痕。我们得出的结论是,无论肾积水的严重程度如何,UPJO婴儿均不建议使用预防性抗生素,因为该人群的UTI风险极低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号